Genetics insight for COVID-19 susceptibility and severity: a review

I Fricke-Galindo, R Falfán-Valencia - Frontiers in immunology, 2021 - frontiersin.org
Coronavirus disease (COVID-19) presents a broad spectrum of clinical manifestations
ranging from an asymptomatic to a severe clinical course. The host genetic background …

The known unknowns of T cell immunity to COVID-19

AC Karlsson, M Humbert, M Buggert - Science Immunology, 2020 - science.org
Tremendous progress has been made in understanding the role of T cell immunity in acute
and convalescent COVID-19 infection. Here, we shed light on the “known unknowns” of …

Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2

JM Francis, D Leistritz-Edwards, A Dunn, C Tarr… - Science …, 2021 - science.org
Effective presentation of antigens by human leukocyte antigen (HLA) class I molecules to
CD8+ T cells is required for viral elimination and generation of long-term immunological …

Human leukocyte antigen complex and other immunogenetic and clinical factors influence susceptibility or protection to SARS-CoV-2 infection and severity of the …

R Littera, M Campagna, S Deidda, G Angioni… - Frontiers in …, 2020 - frontiersin.org
Aim SARS-CoV-2 infection is a world-wide public health problem. Several aspects of its
pathogenesis and the related clinical consequences still need elucidation. In Italy, Sardinia …

Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature

F Migliorini, E Torsiello, F Spiezia, F Oliva… - European Journal of …, 2021 - Springer
The COVID-19 pandemic has markedly impacted on cultural, political, and economic
structures all over the world. Several aspects of its pathogenesis and related clinical …

The influence of HLA genotype on the severity of COVID‐19 infection

DJ Langton, SC Bourke, BA Lie, G Reiff, S Natu… - Hla, 2021 - Wiley Online Library
The impact of COVID‐19 varies markedly, not only between individual patients but also
between different populations. We hypothesised that differences in HLA genes might …

Increased risk of severe clinical course of COVID-19 in carriers of HLA-C* 04: 01

J Weiner, P Suwalski, M Holtgrewe, A Rakitko… - …, 2021 - thelancet.com
Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic,
there has been increasing urgency to identify pathophysiological characteristics leading to …

HLA and AB0 polymorphisms may influence SARS-CoV-2 infection and COVID-19 severity

A Amoroso, P Magistroni, F Vespasiano, A Bella… - …, 2021 - journals.lww.com
Background. SARS-CoV-2 infection is heterogeneous in clinical presentation and disease
evolution. To investigate whether immune response to the virus can be influenced by …

An effective COVID-19 vaccine needs to engage T cells

K Sauer, T Harris - Frontiers in immunology, 2020 - frontiersin.org
Ending the current COVID-19 pandemic and preventing recurrence requires the
development of vaccines that provide long-lasting immunity to the causative virus SARS …

Genome-wide B cell, CD4+, and CD8+ T cell epitopes that are highly conserved between human and animal coronaviruses, identified from SARS-CoV-2 as targets for …

S Prakash, R Srivastava, PG Coulon… - The Journal of …, 2021 - journals.aai.org
Over the last two decades, there have been three deadly human outbreaks of coronaviruses
(CoVs) caused by SARS-CoV, MERS-CoV, and SARS-CoV-2, which has caused the current …